Newsbenzinga
Climb Bio Announces Initial Data From Its Ongoing Phase 1b Portion Of Its Phase 1b/2a Study Evaluating Budoprutug In Adults With Primary Immune Thrombocytopenia
· Published
Article summary
Please check the source for details.
An excerpt from the original article.
Comments —
Loading comments…